NCT00946504已完成1 期
A Two-Way Crossover Bioequivalence Study Comparing Single 10 mg Doses of Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Sandoz
- 入组人数
- 28
- 主要终点
- Bioequivalence based on AUC and Cmax
研究概览
简要总结
To demonstrate the relative bioequivalency comparing Geneva's 10 mg Glipizide tablets to Roerig's 10 mg Glucotrol tablets.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
排除标准
- •Positive test results for HIV or hepatitis B or C.
- •Treatment for drug or alcohol dependence.
研究组 & 干预措施
1
Experimental
Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)
干预措施: Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.) (Drug)
2
Active Comparator
Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)
干预措施: Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.) (Drug)
结局指标
主要结局
Bioequivalence based on AUC and Cmax
时间窗: 9 days
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed ConditionHealthyNCT01053689Dr. Reddy's Laboratories Limited44
已完成
1 期
Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting ConditionHealthyNCT01052909Dr. Reddy's Laboratories Limited44
Unknown
不适用
An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy SubjectsDiabetesHyperglycemiaNCT01195532Taipei Medical University WanFang Hospital40
已完成
1 期
Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)HealthyNCT05804721Genuine Research Center, Egypt29
已完成
1 期
Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)HealthyNCT05855187Genuine Research Center, Egypt30